BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6656012)

  • 1. Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: a pilot study.
    Furusato E; Shen D; Cao X; Furusato B; Nussenblatt RB; Rushing EJ; Chan CC
    Histol Histopathol; 2011 Sep; 26(9):1145-51. PubMed ID: 21751146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic ophthalmia: A comprehensive update.
    Parchand S; Agrawal D; Ayyadurai N; Agarwal A; Gangwe A; Behera S; Bhatia P; Mulkutkar S; Barwar G; Singh R; Sen A; Agarwal M
    Indian J Ophthalmol; 2022 Jun; 70(6):1931-1944. PubMed ID: 35647958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel corneal morphological alterations in Vogt-Koyanagi-Harada disease.
    Hamano Y; Maruyama K; Oie Y; Maeda N; Koh S; Hashida N; Nishida K
    Jpn J Ophthalmol; 2022 Jul; 66(4):358-364. PubMed ID: 35508747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Non-Infectious and/or Immune Mediated Choroiditis: A Brief Overview of the Essentials.
    Herbort CP; Mantovani A; Tugal-Tutkun I; Papasavvas I
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34073914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada syndrome - current perspectives.
    Baltmr A; Lightman S; Tomkins-Netzer O
    Clin Ophthalmol; 2016; 10():2345-2361. PubMed ID: 27932857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.
    Lavezzo MM; Sakata VM; Morita C; Rodriguez EE; Abdallah SF; da Silva FT; Hirata CE; Yamamoto JH
    Orphanet J Rare Dis; 2016 Mar; 11():29. PubMed ID: 27008848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of anti-retina antibodies in asymptomatic patients with chronic t. gondii infection.
    Cursino SR; Costa TB; Yamamoto JH; Meireles LR; Silva MA; Andrade Junior HF
    Clinics (Sao Paulo); 2010; 65(10):1027-32. PubMed ID: 21120306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients.
    Kilmartin DJ; Wilson D; Liversidge J; Dick AD; Bruce J; Acheson RW; Urbaniak SJ; Forrester JV
    Br J Ophthalmol; 2001 Mar; 85(3):281-6. PubMed ID: 11222331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic ophthalmia: an autoimmune ocular inflammatory disease.
    Chan CC; Mochizuki M
    Springer Semin Immunopathol; 1999; 21(2):125-34. PubMed ID: 10457586
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of histopathology in the diagnosis and management of uveitis.
    Côté MA; Rao NA
    Int Ophthalmol; 1990 Oct; 14(5-6):309-16. PubMed ID: 2249908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What should be known of the Vogt-Koyanagi-Harada disease? (author's transl)].
    Fournier A; Bonnin JP; Colomb D
    Sem Hop; 1980 Apr 18-25; 56(15-16):723-7. PubMed ID: 6246605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in sympathetic ophthalmia.
    Marak GE
    Surv Ophthalmol; 1979; 24(3):141-56. PubMed ID: 396680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome.
    Rao NA
    Eye (Lond); 1997; 11 ( Pt 2)():213-6. PubMed ID: 9349415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic ophthalmia simulating vogt-Koyanagi-Harada's disease: a clinico-pathologic study of four cases.
    Rao NA; Marak GE
    Jpn J Ophthalmol; 1983; 27(3):506-11. PubMed ID: 6656012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome.
    Perry HD; Font RL
    Am J Ophthalmol; 1977 Feb; 83(2):242-54. PubMed ID: 836666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological study of the Vogt-Koyanagi-Harada syndrome.
    Lubin JR; Ni C; Albert DM
    Int Ophthalmol Clin; 1982; 22(3):141-56. PubMed ID: 7201983
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.